We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Adenoid Cystic Carcinoma Stem Cells Depend on NOTCH1 and SOX10 Signaling

By LabMedica International staff writers
Posted on 05 May 2016
Print article
Image: An expression of NOTCH 1 (green color) in ACC stem cells (Photo courtesy of Yale University).
Image: An expression of NOTCH 1 (green color) in ACC stem cells (Photo courtesy of Yale University).
Cancer researchers have isolated a stem cell population from the cells making up an adenoid cystic carcinoma (ACC) tumor and showed that the signaling factors NOTCH1 and SOX10 were essential for the cancer stem cells to proliferate and resist radiation treatment.

ACC is a rare and lethal glandular cancer with a high recurrence rate and few treatment options. Although the existence of cancer stem cells (CSC) in ACC had been proposed, lack of assays for their propagation and uncertainty about molecular markers prevented their characterization.

Investigators at Yale University (New Haven, CT, USA) used differential cell culture techniques followed by immunomagnetic cell sorting to isolate CSCs from mixtures of ACC cells. In vitro and in vivo assays for CSC viability and tumorigenicity confirmed their identity.

In a paper published in the April 15, 2016, online edition of the journal Clinical Cancer Research the investigators reported the identification in ACC of CD133-positive CSCs that expressed the signaling factors NOTCH1 and SOX10, formed spheroids, and initiated tumors in nude mice. The rare CD133+ CSC population is one that undergoes self-renewal and differentiation, and can propagate tumors when injected into immune-compromised mice. However, previous studies had indicated the difficulty in isolating pure CSC populations.

The investigators reported that CD133+ ACC cells produced activated NOTCH1 and generated CD133− cells that expressed JAG1 (Jagged1 - one of five cell surface proteins that interact with four receptors in the mammalian Notch signaling pathway) as well as several neural differentiation factors.

The Notch family of transmembrane proteins share structural characteristics including an extracellular domain consisting of multiple epidermal growth factor-like (EGF) repeats, and an intracellular domain consisting of multiple, different domain types. Notch family members play a role in a variety of developmental processes by controlling cell fate decisions. The Notch signaling network is an evolutionarily conserved intercellular signaling pathway that regulates interactions between physically adjacent cells.

“Within ACC cells, we found the especially aggressive cancer stem cells. As important, we found the Achilles heel of these cells, which is their addiction to NOTCH1, a signaling molecule that helps these cells to survive therapy and multiply,” said senior author Dr. Sergey Ivanov, research scientist in surgery at Yale University. “Fortunately, cancer stem cells can be killed by blocking NOTCH1 production.”

Related Links:
Yale University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.